Search Results

25 - 29 of 29 Products for 'genesis 577' Page 3 of 3 |

genesis 577

compatibility matrix 02

compatibility matrix 02

…FLS CL 1064 nm FieldMaxII-TO PM5K FLS A 1064 nm FieldMaxII-TO PM5K QFS 50 1055 - 1070 nm FieldMaxII-TO PM150-50 CW Solid State Laser Genesis Lasers 355 to 577 nm FieldMaxII-TO PM10 Sapphire Laser 458 TO 594 nm FieldMaxII-TO PS10 OBIS Lasers 355 to 785 nm FieldMaxII-TO PS10 Verdi Lasers 532 nm…

34706a cover.indd

34706a cover.indd

…single cells or
populations of cells in a heterogeneous mixture, including blood samples. Our OBIS, Flare, Galaxy,
Sapphire, BioRay and Genesis lasers are used in several bio-instrumentation applications.
Medical Therapy
We sell a variety of components and lasers to medical laser…

32311a coverSinglesRR.indd

32311a coverSinglesRR.indd

…single cells or
populations of cells in a heterogeneous mixture, including blood samples. Our OBIS, Flare, Galaxy,
Sapphire, BioRay and Genesis lasers are used in several bio-instrumentation applications.
Medical Therapy
We sell a variety of components and lasers to medical laser…

Coherent

Coherent

…for the
treatment of eye related diseases, such as Age Related Macular Degeneration and retinal diseases
associated with diabetes. The 577nm wavelength was designed to match the peak in absorption of
oxygenated hemoglobin thereby allowing treatment to occur at a lower power level,…

Bio Photonics - April 2015

Bio Photonics - April 2015

…2. The effectiveness of STED is clear in this pair of images of fluorescently tagged
microtubuli in mammalian cells using a 577-nm Coherent Genesis laser to drive the STED
effect: conventional confocal (left) and gated STED image (right). Image courtesy of Dr. Giuseppe
Vicidomini and…

Powered by Site Search powered by SLI Systems

Please Read Before Continuing

Risk factors: Except for the historical information contained here, many of the matters discussed in this Web site are forward-looking statements, based on expectations at the time they were made, that involve risks and uncertainties that could cause our results to differ materially from those expressed or implied by such statements. These risks are detailed in the “Factors That May Affect Future Results” section of our latest 10-K or 10-Q filing. Coherent assumes no obligation to update these forward-looking statements.


I have read the terms and conditions